You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Liposomal doxorubicin

Showing 26 - 50 of 2,209
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Platinum-resistant Ovarian Cancer, Fallopian Tube Cancer, Epithelial Ovarian Cancer Trial (Pegylated Liposomal Doxorubicin +

Not yet recruiting
  • Platinum-resistant Ovarian Cancer
  • +6 more
  • Pegylated Liposomal Doxorubicin + SL-172154
  • Mirvetuximab + SL-172154
  • (no location specified)
Jul 29, 2022

Breast Cancer Trial in Prague, Haifa, Candiolo (drug, radiation, device)

Withdrawn
  • Breast Cancer
  • ThermoDox (Thermally Sensitive Liposomal Doxorubicin)
  • +2 more
  • Prague, Czechia
  • +2 more
Mar 29, 2022

Breast Cancer Trial in Guandong (pegylated liposomal doxorubicin (PLD), cyclophosphamide (C), trastuzumab (H))

Recruiting
  • Breast Cancer
  • pegylated liposomal doxorubicin (PLD)
  • +5 more
  • Guandong, Guangdong, China
    Sunyat-sen Memorial Hospital
Feb 17, 2022

Ovarian Cancer Trial in Indianapolis, Madison (Doxil (Pegylated Liposomal Doxorubicin), BIBF 1120)

Terminated
  • Ovarian Cancer
  • Doxil (Pegylated Liposomal Doxorubicin)
  • BIBF 1120
  • Indianapolis, Indiana
  • +1 more
Feb 14, 2022

Advanced Breast Cancer Trial in Shanghai (Pegylated Liposomal Doxorubicin)

Recruiting
  • Advanced Breast Cancer
  • Pegylated Liposomal Doxorubicin
  • Shanghai, China
    Fudan University Cancer Hospital
Apr 19, 2022

Solid Tumors Trial in Milano, Bellinzona, Chur (AZD2281, liposomal doxorubicin)

Active, not recruiting
  • Solid Tumors
  • Milano, Italy
  • +2 more
Nov 17, 2021

Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in Santa Monica, Pittsburgh, Houston (TTI-622, Pegylated Liposomal

Recruiting
  • Ovarian Cancer
  • +5 more
  • TTI-622
  • Pegylated Liposomal Doxorubicin
  • Santa Monica, California
  • +4 more
Jul 26, 2022

Advanced Solid Tumors Trial in Switzerland (TLD-1, Caelyx)

Recruiting
  • Advanced Solid Tumors
  • Bellinzona, Switzerland
  • +3 more
Dec 24, 2021

Pediatric Cancer, Solid Tumors, Rhabdomyosarcoma Trial in Washington (Magnetic resonance high intensity focused ultrasound,

Recruiting
  • Pediatric Cancer
  • +9 more
  • Magnetic resonance high intensity focused ultrasound
  • Lyso-thermosensitive liposomal doxorubicin
  • Washington, District of Columbia
    Children's National Medical Center
Dec 10, 2021

Breast Cancer Trial in Taiwan (Epirubicin+Cyclophosphamide, liposomal-doxorubicin+Cyclophosphamide)

Active, not recruiting
  • Breast Cancer
  • Changhua, Taiwan
  • +8 more
Nov 22, 2021

Ovarian Cancer Trial in Villejuif (Pembrolizumab, Bevacizumab, pegylated liposomal doxorubicin (PLD))

Active, not recruiting
  • Ovarian Cancer
  • Villejuif, Val De Marne, France
    Gustave Roussy
Jul 21, 2021

Ovarian Cancer Trial (EC145, Pegylated Liposomal Doxorubicin (PLD/Doxil®/Caelyx®), )

Terminated
  • Ovarian Cancer
  • (no location specified)
Sep 24, 2021

Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer Trial in New

Suspended
  • Estrogen Receptor-negative Breast Cancer
  • +8 more
  • pegylated liposomal doxorubicin hydrochloride
  • +6 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Sep 20, 2021

Breast Cancer Trial in Wuhan (Camrelizumab, Liposomal Doxorubicin, Losartan)

Not yet recruiting
  • Breast Cancer
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College of HUST
Oct 27, 2021

Gastric Cancer Trial in Shanghai (PLD, Oxaliplatin, Capecitabine)

Recruiting
  • Gastric Cancer
  • Shanghai, China
    Shanghai General Hospital
Sep 7, 2022

Solid Tumors, Soft Tissue Sarcoma, Ewing Sarcoma Trial (Magnetic Resonance-Guided High Intensity Focused Ultrasound,

Not yet recruiting
  • Solid Tumors
  • +8 more
  • Magnetic Resonance-Guided High Intensity Focused Ultrasound
  • Lyso-thermosensitive Liposomal Doxorubicin
  • (no location specified)
Mar 10, 2022

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Carcinoma Trial in United States (Pazopanib, Doxil)

Terminated
Has Results
  • Ovarian Cancer
  • +2 more
  • Fort Myers, Florida
  • +3 more
Oct 4, 2021

Lymphoproliferative Disorder, HHV-8, Malignancy Trial run by the National Cancer Institute (NCI) (Etoposide, Interferon-alpha,

Active, not recruiting
  • Lymphoproliferative Disorder
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

Sarcoma Trial in Baltimore, Minneapolis (biological, drug, procedure, radiation)

Active, not recruiting
  • Sarcoma
  • pegfilgrastim
  • +5 more
  • Baltimore, Maryland
  • +1 more
Mar 25, 2022

Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Stage IV, Pancreatic Cancer Non-resectable Trial in Oxford (Focused

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +3 more
  • Focused Ultrasound
  • +2 more
  • Oxford, United Kingdom
    Oxford University Hospitals NHS Trust
Feb 22, 2022

Metastatic Triple Negative Breast Cancer Trial in Dallas (PLD Chemotherapy, CDX-1140, CDX-301)

Recruiting
  • Metastatic Triple Negative Breast Cancer
  • PLD Chemotherapy
  • +2 more
  • Dallas, Texas
    UT Southwestern Medical Center
Jun 23, 2022

Low Grade Serous Ovarian Cancer Trial (avutometinib + defactinib, Investigator Choice of Treatment (ICT))

Not yet recruiting
  • Low Grade Serous Ovarian Cancer
  • avutometinib + defactinib
  • Investigator Choice of Treatment (ICT)
  • (no location specified)
Oct 2, 2023

Efficacy and Safety Trial in Zhejiang (pegylated liposomal doxorubicin, paclitaxel, Carboplatin)

Active, not recruiting
  • Efficacy and Safety
  • pegylated liposomal doxorubicin
  • +2 more
  • Zhejiang, Hangzhou, China
    Women's Hospital School Of Medicine Zhejiang University
Jul 14, 2022

Lymphoma Trial in Shanghai (liposomal doxorubicin)

Recruiting
  • Lymphoma
  • liposomal doxorubicin
  • Shanghai, Shanghai, China
    Ruijin Hospital
Mar 13, 2021

Breast Cancer, Chemotherapeutic Toxicity Trial in Hanzhou (Liposomal doxorubicin + Cyclophosphamide vs Docetaxel +

Recruiting
  • Breast Cancer
  • Chemotherapeutic Toxicity
  • Liposomal doxorubicin + Cyclophosphamide vs Docetaxel + Cyclophosphamide
  • Hanzhou, Zhejing, China
    Second Affiliated Hospital, School of Medicine, Zhejiang Univers
Apr 7, 2022